Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the acquisition of leading biolab TetraQ, based at...

Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021

Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials...

Viva Biotech Announced 2020 Annual Results

      The Group's Revenue Surged by 115.7% YoY Revenue from the CFS Business Increased Significantly by 146.3% YoY Establish One-stop Service Platform for Novel...

Azelis releases ‘Action 2025’, confirming sustainability as a key driver in growth strategy

Azelis, an innovation service provider, is excited to release its sustainability strategy, 'Action 2025', reinforcing its commitment to become the world-leading provider of sustainable...

China Medical System (0867) Ushers in a Revaluation with its Continuous Growth and Synergy...

Turnover and net profit increased at the same time, innovative pipeline continued to expand, and the synergy between its businesses became increasingly obvious .....China...

TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical...

Two Self-Developed Drugs Are Expected to be Approved for Marketing in 2021 TOT BIOPHARM International Company Limited (stock code: 1875.HK), a clinical-stage biopharmaceutical company dedicated...

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

TrialWire™, the most secure digital Patient Recruitment Platform, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost...

Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity

By Accelerating New Drug Development and Employing New Online Platforms Sales of New Drugs Marketed over Past Three Years Double to RMB8.06 Billion Sino Biopharmaceutical Limited...

Black Spade Capital Announces Acquisition of iRad Medical Holding

The addition of the largest specialist medical imaging practice in Hong Kong to Black Spade's investment portfolio highlights the family office's bullish view on...

Jicheng Lyu: The Philanthropic Prophet

During 10 years of philanthropic activism, Jicheng Lyu sets himself apart from the rest with an inspiring record of ongoing service and a nomination...

Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine’s Dorzagliatin Readying for NDA...

Hua Medicine (the "Company", Stock Code: 2552.HK), today announces the audited annual results of the Company and its subsidiaries for the year ended December...

Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its world-class immunoassay and immunobiology...

The third TDMall in the world opened in Sydney, Australia

TDMall (Group) Limited, a subsidiary of Tianda Pharmaceuticals Limited (listed on the main board of the Hong Kong Stock Exchange: 00455) has invested in...

Alvotech Completes Second Round of a US$100 Million Private Placement

Multinational biopharmaceutical company Alvotech has successfully completed a second round of its US$100 million private placement, for US$35 million. The first round which was completed...

Size matters: Bimodal imaging receives nanoparticle enhancement

A nanoparticle's size is fine-tuned to offer high-resolution images before and during surgical procedures. Scientists have found a way to control the size of special...

Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer

Fibrogen veteran brings global R&D expertise to Management Team Merck KGaA Executive Sophie (Zhengjie) Sun named Senior Vice President, Corporate Development bringing partnership,...

Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and...

Tianda Pharmaceuticals Limited ("Tianda Pharmaceuticals", together with its subsidiaries as the "Group", Stock Code: 455.HK) is pleased to announce that its wholly-owned subsidiary, Tianda...

APOLLOMICS, INC ANNOUNCES SUCCESSFUL ENROLLMENT OF FIRST PATIENT INTO PHASE 1 CLINICAL TRIAL OF...

Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the first patient...

Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New...

Multinational biopharmaceutical company Alvotech and Gulf FZ LCC ("Cipla Gulf"), subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as "Cipla" today...

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery...

Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD (Age-related Macular Degeneration) and...